跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEPTRA PEDIATRIC ORAL SUSPENSION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SEPTRA PEDIATRIC ORAL SUSPENSION
Authorized
STANDARD
SEPTRA PEDIATRIC ORAL SUSPENSION
Aspen Pharmacare Canada Inc.
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
a929144a3c5fc3c2
Company
Aspen Pharmacare Canada Inc.
Type
Standard
Approval Details
Approval Id
a929144a3c5fc3c2
Drug Approval Canada Name
SEPTRA PEDIATRIC ORAL SUSPENSION
Product Name
SEPTRA PEDIATRIC ORAL SUSPENSION
Status
Approved
Status Date
2025-12-05
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.20
Atc Original
J01EE01 SULFAMETHOXAZOLE AND TRIMETHOPRIM
Aig Number
0208901002
Company Name
Aspen Pharmacare Canada Inc.
Company Address
2030 Bristol Circle, Suite 201 Oakville Ontario Canada L6H 0H2
Company Detail Path
/organization/aspen-pharmacare-canada-inc
Company Information
Pharmaceutical Company Name
Aspen Pharmacare Canada Inc.
Country Name
Canada
Province Name
Ontario
City Name
oakville,ontario,country_ca
Address
8-1155 North Service Rd W
Website
http://www.aspenpharma.com/
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
a929144a3c5fc3c2
Type
Standard
Back to Health Canada Approvals